Disruption of Mitotic Progression by Arsenic
Related Experiment Video
Updated: Apr 16, 2026

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration
Published on: February 23, 2019
1Department of Pharmacology and Toxicology, University of Louisville, 505 S. Hancock St, Louisville, KY, 40202, USA, jcstates@louisville.edu.
Abstract:
Arsenic is an enigmatic xenobiotic that causes a multitude of chronic diseases including cancer and also is a therapeutic with promise in cancer treatment. Arsenic causes mitotic delay and induces aneuploidy in diploid human cells. In contrast, arsenic causes mitotic arrest followed by an apoptotic death in a multitude of virally transformed cells and cancer cells. We have explored the hypothesis that these differential effects of arsenic exposure are related by arsenic disruption of mitosis and are differentiated by the target cell's ability to regulate or modify cell cycle checkpoints. Functional p53/CDKN1A axis has been shown to mitigate the mitotic block and to be essential to induction of aneuploidy. More recent preliminary data suggest that microRNA modulation of chromatid cohesion also may play a role in escape from mitotic block and in generation of chromosomal instability. Other recent studies suggest that arsenic may be useful in treatment of solid tumors when used in combination with other cytotoxic agents such as cisplatin.
Insights
Arsenic
Area of Science:
- Toxicology
- Cell Biology
- Cancer Research
Background:
- Arsenic is a xenobiotic with dual roles in disease and therapy.
- It differentially affects cell division in normal versus cancer cells.
- Understanding these differences is key to its therapeutic application.
Purpose of the Study:
- To explore the hypothesis that arsenic's differential effects on cell mitosis are linked to cell cycle checkpoint regulation.
- To investigate the roles of p53/CDKN1A axis and microRNA in arsenic-induced mitotic disruption and aneuploidy.
- To understand arsenic's potential in combination cancer therapy.
Main Methods:
- Investigated arsenic's effects on mitosis in diploid human cells versus virally transformed/cancer cells.
- Examined the role of the p53/CDKN1A pathway in mitigating mitotic block and inducing aneuploidy.
- Reviewed preliminary data on microRNA's role in chromatid cohesion and chromosomal instability.
Main Results:
- Arsenic induces mitotic delay and aneuploidy in normal cells.
- Arsenic causes mitotic arrest and apoptosis in cancer cells.
- Functional p53/CDKN1A axis mitigates mitotic block and is essential for aneuploidy induction.
Conclusions:
- Differential cellular responses to arsenic are linked to cell cycle checkpoint regulation.
- MicroRNA modulation may influence escape from mitotic block and chromosomal instability.
- Arsenic shows promise as a therapeutic agent, particularly in combination with other cytotoxic drugs for solid tumors.
Related Concept Videos
Drugs that Destabilize Microtubules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Drugs that Stabilize Microtubules

